AbbVie
ABBV
ABBV
1,726 hedge funds and large institutions have $71.3B invested in AbbVie in 2017 Q1 according to their latest regulatory filings, with 123 funds opening new positions, 651 increasing their positions, 742 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
4% more capital invested
Capital invested by funds: $68.3B → $71.3B (+$2.93B)
2% less funds holding in top 10
Funds holding in top 10: 85 → 83 (-2)
12% less repeat investments, than reductions
Existing positions increased: 651 | Existing positions reduced: 742
Holders
1,726
Holding in Top 10
83
Calls
$1.25B
Puts
$1.07B
Top Buyers
| 1 | +$5.55B | |
| 2 | +$258M | |
| 3 | +$244M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$168M |
| 5 |
D.E. Shaw & Co
New York
|
+$157M |
Top Sellers
| 1 | -$372M | |
| 2 | -$293M | |
| 3 | -$179M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$131M |
| 5 |
Two Sigma Advisers
New York
|
-$128M |